619 related articles for article (PubMed ID: 19017556)
1. Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke.
Dharmasaroja P
J Clin Neurosci; 2009 Jan; 16(1):12-20. PubMed ID: 19017556
[TBL] [Abstract][Full Text] [Related]
2. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats.
Koh SH; Kim KS; Choi MR; Jung KH; Park KS; Chai YG; Roh W; Hwang SJ; Ko HJ; Huh YM; Kim HT; Kim SH
Brain Res; 2008 Sep; 1229():233-48. PubMed ID: 18634757
[TBL] [Abstract][Full Text] [Related]
3. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
[TBL] [Abstract][Full Text] [Related]
4. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine.
Tomar GB; Srivastava RK; Gupta N; Barhanpurkar AP; Pote ST; Jhaveri HM; Mishra GC; Wani MR
Biochem Biophys Res Commun; 2010 Mar; 393(3):377-83. PubMed ID: 20138833
[TBL] [Abstract][Full Text] [Related]
5. The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion.
Gan Y; Dai K; Zhang P; Tang T; Zhu Z; Lu J
Biomaterials; 2008 Oct; 29(29):3973-82. PubMed ID: 18639333
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells: isolation, in vitro expansion and characterization.
Beyer Nardi N; da Silva Meirelles L
Handb Exp Pharmacol; 2006; (174):249-82. PubMed ID: 16370331
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.
Arinzeh TL
Foot Ankle Clin; 2005 Dec; 10(4):651-65, viii. PubMed ID: 16297825
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.
Karussis D; Kassis I; Kurkalli BG; Slavin S
J Neurol Sci; 2008 Feb; 265(1-2):131-5. PubMed ID: 17610906
[TBL] [Abstract][Full Text] [Related]
9. Human bone marrow mesenchymal stem cells in vivo.
Jones E; McGonagle D
Rheumatology (Oxford); 2008 Feb; 47(2):126-31. PubMed ID: 17986482
[TBL] [Abstract][Full Text] [Related]
10. Trafficking and differentiation of mesenchymal stem cells.
Liu ZJ; Zhuge Y; Velazquez OC
J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow mesenchymal stem cells form ectopic woven bone in vivo through endochondral bone formation.
Chang SC; Tai CL; Chung HY; Lin TM; Jeng LB
Artif Organs; 2009 Apr; 33(4):301-8. PubMed ID: 19335406
[TBL] [Abstract][Full Text] [Related]
12. Concise review: mesenchymal stromal cells: potential for cardiovascular repair.
Psaltis PJ; Zannettino AC; Worthley SG; Gronthos S
Stem Cells; 2008 Sep; 26(9):2201-10. PubMed ID: 18599808
[TBL] [Abstract][Full Text] [Related]
13. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
Chen MY; Lie PC; Li ZL; Wei X
Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell homing capacity.
Sordi V
Transplantation; 2009 May; 87(9 Suppl):S42-5. PubMed ID: 19424004
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells.
Kanehira M; Xin H; Hoshino K; Maemondo M; Mizuguchi H; Hayakawa T; Matsumoto K; Nakamura T; Nukiwa T; Saijo Y
Cancer Gene Ther; 2007 Nov; 14(11):894-903. PubMed ID: 17693990
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation?
Mishra PK
J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):122-8. PubMed ID: 18192802
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of genetically modified mesenchymal stem cells.
Kumar S; Chanda D; Ponnazhagan S
Gene Ther; 2008 May; 15(10):711-5. PubMed ID: 18356815
[TBL] [Abstract][Full Text] [Related]
18. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
Phinney DG; Prockop DJ
Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
20. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases.
Sadan O; Melamed E; Offen D
Expert Opin Biol Ther; 2009 Dec; 9(12):1487-97. PubMed ID: 19821796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
